Product Review – Gla-300 in patients with type 2 diabetes mellitus: Sustained glycaemic control with lower risk of hypoglycaemia and observed lower weight gain
Educational Series – Navigating the landscape for moderate-to-severe systemic lupus erythematosus management in Australia
EASD Highlights 2025
Endocrinology Watch 14 – Orforglipron: A novel oral GLP-1 receptor agonist for obesity
Upper GI Cancer Watch 6 – MATTERHORN Breakthrough: Enhancing Outcomes in Resectable Gastric and GOJ Adenocarcinomas with Durvalumab Plus FLOT
Gastroenterology Watch 30 – Long-term outcomes after ICU admission in critically ill patients with liver cirrhosis: An Australian state-wide cohort study
IBD Watch 13 – Steroid use and misuse in inflammatory bowel disease
